SCHEMBL9749786

SCHEMBL9749786

CCOC(=O)CCc1nsnc1OCC(O)CN(O)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.33
CASR P41180 3/20 0.31
ADRB2 P07550 2/20 0.31
CYP2D6 P10635 2/20 0.31
SLC6A2 P23975 2/20 0.31
SLC6A4 P31645 2/20 0.31
SLC6A3 Q01959 2/20 0.31
KCNH2 Q12809 2/20 0.31
TNF P01375 1/20 0.31
LMNA P02545 2/20 0.31
KDM4E B2RXH2 2/20 0.30
HSD17B10 Q99714 2/20 0.30
ALDH1A1 P00352 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
BLM P54132 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9749863 0.89 ADRB2 (0.33) ADRB2CYP2D6KDM4ESMN1; SMN2BLM
SCHEMBL10372339 0.83 LMNA (0.39) CHRM1LMNAKDM4EHSD17B10ALDH1A1
SCHEMBL9749811 0.82 ADRB2 (0.47) CASRADRB2CYP2D6SMN1; SMN2BLM
SCHEMBL10980202 0.80 KDM4E (0.32) ADRB2CYP2D6KDM4EHSD17B10SMN1; SMN2
SCHEMBL10997074 0.79 CASR (0.41) CASRADRB2CYP2D6SLC6A2SLC6A4
SCHEMBL10980025 0.75 ADRB2 (0.43) CASRADRB2CYP2D6SLC6A2SLC6A4
SCHEMBL9750371 0.75 ALDH1A1 (0.36) LMNAKDM4EHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL10991737 0.74 ADRB2 (0.35) ADRB2
SCHEMBL10989125 0.73 ADRB2 (0.41) ADRB2
SCHEMBL9749804 0.71 ADRB2 (0.50) ADRB2CYP2D6SMN1; SMN2BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0131006-B1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-06-10 EP claimed
EP-0131006-A4 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. AMERICAN HOSPITAL SUPPLY CORP (US) 1985-06-06 EP claimed
US-4508725-A BETA-ADRENERGIC BLOCKING AGENTS; GLAUCOMA TREATMENT AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1985-04-02 US claimed
EP-0131006-A1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. AMERICAN HOSPITAL SUPPLY CORP (US) 1985-01-16 EP claimed
WO-1984002525-A1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES AMERICAN HOSPITAL SUPPLY CORP (US) 1984-07-05 WO claimed
EP-0131006-B1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-06-10 EP disclosed
EP-0131006-A4 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. AMERICAN HOSPITAL SUPPLY CORP (US) 1985-06-06 EP disclosed
US-4508725-A BETA-ADRENERGIC BLOCKING AGENTS; GLAUCOMA TREATMENT AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1985-04-02 US disclosed
EP-0131006-A1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. AMERICAN HOSPITAL SUPPLY CORP (US) 1985-01-16 EP disclosed
WO-1984002525-A1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES AMERICAN HOSPITAL SUPPLY CORP (US) 1984-07-05 WO disclosed